ORANGE BELGIUM (OBEL.BR) Stock Fundamental Analysis

Europe • Euronext Brussels • EBR:OBEL • BE0003735496

19.5 EUR
+0.25 (+1.3%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to OBEL. OBEL was compared to 6 industry peers in the Wireless Telecommunication Services industry. OBEL has a medium profitability rating, but doesn't score so well on its financial health evaluation. OBEL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year OBEL was profitable.
  • OBEL had a positive operating cash flow in the past year.
  • Each year in the past 5 years OBEL has been profitable.
  • Each year in the past 5 years OBEL had a positive operating cash flow.
OBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFOBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • OBEL has a Return On Assets (0.93%) which is comparable to the rest of the industry.
  • OBEL has a better Return On Equity (3.88%) than 66.67% of its industry peers.
  • With a decent Return On Invested Capital value of 3.63%, OBEL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for OBEL is below the industry average of 6.49%.
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROIC 3.64%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
OBEL.BR Yearly ROA, ROE, ROICOBEL.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • The Profit Margin of OBEL (1.89%) is worse than 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of OBEL has declined.
  • OBEL has a Operating Margin (7.62%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of OBEL has grown nicely.
  • OBEL has a Gross Margin of 68.11%. This is amongst the best in the industry. OBEL outperforms 100.00% of its industry peers.
  • OBEL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
OBEL.BR Yearly Profit, Operating, Gross MarginsOBEL.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • OBEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, OBEL has more shares outstanding
  • Compared to 5 years ago, OBEL has more shares outstanding
  • The debt/assets ratio for OBEL has been reduced compared to a year ago.
OBEL.BR Yearly Shares OutstandingOBEL.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OBEL.BR Yearly Total Debt VS Total AssetsOBEL.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • OBEL has an Altman-Z score of 0.96. This is a bad value and indicates that OBEL is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.96, OBEL is doing worse than 66.67% of the companies in the same industry.
  • OBEL has a debt to FCF ratio of 23.91. This is a negative value and a sign of low solvency as OBEL would need 23.91 years to pay back of all of its debts.
  • The Debt to FCF ratio of OBEL (23.91) is worse than 83.33% of its industry peers.
  • A Debt/Equity ratio of 1.92 is on the high side and indicates that OBEL has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.92, OBEL is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Altman-Z 0.96
ROIC/WACC0.69
WACC5.28%
OBEL.BR Yearly LT Debt VS Equity VS FCFOBEL.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • OBEL has a Current Ratio of 0.49. This is a bad value and indicates that OBEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • OBEL has a Current ratio of 0.49. This is amonst the worse of the industry: OBEL underperforms 83.33% of its industry peers.
  • A Quick Ratio of 0.46 indicates that OBEL may have some problems paying its short term obligations.
  • The Quick ratio of OBEL (0.46) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.46
OBEL.BR Yearly Current Assets VS Current LiabilitesOBEL.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 780.62% over the past year.
  • The Earnings Per Share has been decreasing by -9.64% on average over the past years.
  • OBEL shows a decrease in Revenue. In the last year, the revenue decreased by -0.39%.
  • OBEL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.26% yearly.
EPS 1Y (TTM)780.62%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%119.69%
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%-1.52%

3.2 Future

  • Based on estimates for the next years, OBEL will show a very negative growth in Earnings Per Share. The EPS will decrease by -12.63% on average per year.
  • OBEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.24% yearly.
EPS Next Y-6.88%
EPS Next 2Y-36.27%
EPS Next 3Y-36.38%
EPS Next 5Y-12.63%
Revenue Next Year4.91%
Revenue Next 2Y2.42%
Revenue Next 3Y3.44%
Revenue Next 5Y2.24%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OBEL.BR Yearly Revenue VS EstimatesOBEL.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
OBEL.BR Yearly EPS VS EstimatesOBEL.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 32.50, the valuation of OBEL can be described as expensive.
  • Based on the Price/Earnings ratio, OBEL is valued a bit more expensive than 66.67% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.93, OBEL is valued at the same level.
  • OBEL is valuated quite expensively with a Price/Forward Earnings ratio of 93.26.
  • Based on the Price/Forward Earnings ratio, OBEL is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of OBEL to the average of the S&P500 Index (27.77), we can say OBEL is valued expensively.
Industry RankSector Rank
PE 32.5
Fwd PE 93.26
OBEL.BR Price Earnings VS Forward Price EarningsOBEL.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, OBEL is valued cheaper than 83.33% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, OBEL is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.95
EV/EBITDA 5.42
OBEL.BR Per share dataOBEL.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The decent profitability rating of OBEL may justify a higher PE ratio.
  • OBEL's earnings are expected to decrease with -36.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.27%
EPS Next 3Y-36.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for OBEL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORANGE BELGIUM

EBR:OBEL (2/6/2026, 7:00:00 PM)

19.5

+0.25 (+1.3%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)02-06
Earnings (Next)07-22
Inst Owners5.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.31B
Revenue(TTM)1.98B
Net Income(TTM)37.35M
Analysts77.78
Price Target17.34 (-11.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15.7%
PT rev (3m)-15.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)184.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 32.5
Fwd PE 93.26
P/S 0.66
P/FCF 14.95
P/OCF 2.78
P/B 1.37
P/tB N/A
EV/EBITDA 5.42
EPS(TTM)0.6
EY3.08%
EPS(NY)0.21
Fwd EY1.07%
FCF(TTM)1.3
FCFY6.69%
OCF(TTM)7.01
OCFY35.97%
SpS29.36
BVpS14.28
TBVpS-9.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.88
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROCE 4.85%
ROIC 3.64%
ROICexc 3.7%
ROICexgc 7.68%
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
FCFM 4.44%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
ROICexc(3y)4.56%
ROICexc(5y)5.09%
ROICexgc(3y)11.41%
ROICexgc(5y)10.53%
ROCE(3y)6.22%
ROCE(5y)6.69%
ROICexgc growth 3Y-7.87%
ROICexgc growth 5Y2.19%
ROICexc growth 3Y-16.49%
ROICexc growth 5Y-3.51%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Debt/EBITDA 2.97
Cap/Depr 81.82%
Cap/Sales 19.45%
Interest Coverage 1.49
Cash Conversion 76.13%
Profit Quality 235.44%
Current Ratio 0.49
Quick Ratio 0.46
Altman-Z 0.96
F-Score7
WACC5.28%
ROIC/WACC0.69
Cap/Depr(3y)156.85%
Cap/Depr(5y)119.41%
Cap/Sales(3y)34.82%
Cap/Sales(5y)26.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)780.62%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%119.69%
EPS Next Y-6.88%
EPS Next 2Y-36.27%
EPS Next 3Y-36.38%
EPS Next 5Y-12.63%
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%-1.52%
Revenue Next Year4.91%
Revenue Next 2Y2.42%
Revenue Next 3Y3.44%
Revenue Next 5Y2.24%
EBIT growth 1Y12.37%
EBIT growth 3Y22.15%
EBIT growth 5Y18.64%
EBIT Next Year291.76%
EBIT Next 3Y55.8%
EBIT Next 5Y30.59%
FCF growth 1Y116.96%
FCF growth 3Y-9.07%
FCF growth 5Y-7.65%
OCF growth 1Y24.22%
OCF growth 3Y10.98%
OCF growth 5Y8.17%

ORANGE BELGIUM / OBEL.BR FAQ

Can you provide the ChartMill fundamental rating for ORANGE BELGIUM?

ChartMill assigns a fundamental rating of 3 / 10 to OBEL.BR.


Can you provide the valuation status for ORANGE BELGIUM?

ChartMill assigns a valuation rating of 3 / 10 to ORANGE BELGIUM (OBEL.BR). This can be considered as Overvalued.


How profitable is ORANGE BELGIUM (OBEL.BR) stock?

ORANGE BELGIUM (OBEL.BR) has a profitability rating of 6 / 10.


How financially healthy is ORANGE BELGIUM?

The financial health rating of ORANGE BELGIUM (OBEL.BR) is 0 / 10.


What is the earnings growth outlook for ORANGE BELGIUM?

The Earnings per Share (EPS) of ORANGE BELGIUM (OBEL.BR) is expected to decline by -6.88% in the next year.